The Global Drug Delivery Market: Research Trends and Market Outlook

Table of Contents

1 Introducing the Field of Drug Delivery

• 1.1 The Value of Drug Delivery Systems
• 1.2 Drug Delivery and Product Differentiation
• 1.3 Drug Delivery and Patent Extension
• 1.4 The Optimal Time for Reformulation
• 1.5 Optimizing R&D Returns Through Drug Delivery
• 1.6 Opportunities and Threats to the Drug Delivery Sector
  • 1.6.1 Opportunities for Growth in the Drug Delivery Sector
  • 1.6.2 Threats to Additional Growth in the Drug Delivery Sector
• 1.7 Business Models of Drug Delivery Companies

2 An Overview of Drug Delivery Technologies

• 2.1 Oral Drug Delivery
  • 2.1.1 Controlled Release
  • 2.1.2 Sustained Release
  • 2.1.3 Chronomodulation
  • 2.1.4 Rapid Dissolving and Taste-masking Tablets
  • 2.1.5 Macromolecular Drug Delivery
• 2.2 Inhalable Drug Delivery
  • 2.2.1 Nebulizers
  • 2.2.2 Metered Dose Inhalers (MDIs)
  • 2.2.3 Dry Powder Inhalers (DPIs)
  • 2.2.4 Limitations of Pulmonary Delivery Systems for Systemic Delivery
  • 2.2.5 Aqueous Systems
• 2.3 Injectable Drug Delivery
  • 2.3.1 Sustained Release Injectable Systems
  • 2.3.2 Liposomal Systems
  • 2.3.3 Needleless Systems
• 2.4 Transmucosal Drug Delivery
  • 2.4.1 Buccal Delivery
  • 2.4.2 Nasal
  • 2.4.3 Rectal
  • 2.4.4 Vaginal
• 2.5 Transdermal Drug Delivery
  • 2.5.1 Passive Formulations
  • 2.5.2 Active Formulations
• 2.6 Niche Technologies
  • 2.6.1 Topical Systems
  • 2.6.2 Gene Delivery
  • 2.6.3 Implantable Systems
  • 2.6.4 Drug Delivery Microchips
  • 2.6.5 Nanotechnology

3 Drug Delivery Market Analysis

• 3.1 Key Market Segments
  • 3.1.1 Oral Drug Delivery
    • 3.1.1.1 Sales of Products Utilizing Oral Drug Delivery Technology
    • 3.1.1.2 Key Therapeutic Areas for Oral Drug Delivery
    • 3.1.1.3 Key Oral Drug Delivery Products Impacting Global Market
    • 3.1.1.4 The Outlook for Oral Drug Delivery Technology
  • 3.1.2 Inhalable Drug Delivery
    • 3.1.2.1 Sales of Products Utilizing Inhalable Drug Delivery
    • 3.1.2.2 Key Therapeutic Areas for Inhalable Drug Delivery
    • 3.1.2.3 Key Inhalable Drug Delivery Products Impacting Global Market
    • 3.1.2.4 The Outlook for Inhalable Drug Delivery Technology
  • 3.1.3 Injectable Drug Delivery
    • 3.1.3.1 Sales of Products Utilizing Injectable Drug Delivery Technology
    • 3.1.3.2 Key Therapeutic Areas for Injectable Drug Delivery
    • 3.1.3.3 Key Injectable Drug Delivery Products Impacting Global Market
    • 3.1.3.4 The Outlook for Injectable Drug Delivery Technology
  • 3.1.4 Transmucosal Drug Delivery
    • 3.1.4.1 Sales of Products Utilizing Transmucosal Drug Delivery Technology
    • 3.1.4.2 Key Therapeutic Areas for Transmucosal Delivery
    • 3.1.4.3 Key Transmucosal Drug Delivery Products Impacting Global Market
    • 3.1.4.4 The Outlook for Transmucosal Drug Delivery Technology
  • 3.1.5 Transdermal Drug Delivery
    • 3.1.5.1 Sales of Products Utilizing Transdermal Drug Delivery Technology
    • 3.1.5.2 Key Therapeutic Areas for Transdermal Drug Delivery
    • 3.1.5.3 Key Transdermal Drug Delivery Products Impacting Global Market
    • 3.1.5.4 The Outlook for Transdermal Drug Delivery Technology
  • 3.1.6 Niche Drug Delivery Technologies
    • 3.1.6.1 Sales of Products Utilizing Niche Drug Delivery Technologies
    • 3.1.6.2 Key Niche Drug Delivery Technology Product Impacting Global Market
    • 3.1.6.3 The Outlook for Niche Drug Delivery Technologies

4 Emerging Drug Delivery Technologies: Oral Drug Delivery

• 4.1 Key Product Profiles
• 4.2 Key Company Involvement in the Field of Oral Drug Delivery
  • 4.2.1 ALZA
  • 4.2.2 Biovail
  • 4.2.3 Cardinal Health
  • 4.2.4 Depomed
  • 4.2.5 Emisphere
  • 4.2.6 Ethypharm
  • 4.2.7 Penwest

5 Emerging Drug Delivery Technologies: Inhalable Drug Delivery

• 5.1 Key Product Profiles
• 5.2 Key Company Involvement in the Field of Inhalable Drug Delivery
  • 5.2.1 3M
  • 5.2.2 Alkermes
  • 5.2.3 Aradigm
  • 5.2.4 Nektar
  • 5.2.5 SkyePharma

6 Emerging Drug Delivery Technologies: Injectable Drug Delivery

• 6.1 Key Product Profiles
• 6.2 Key Company Involvement in the Field of Injectable Drug Delivery
  • 6.2.1 Alkermes
  • 6.2.2 ALZA
  • 6.2.3 Aradigm
  • 6.2.4 Enzon
  • 6.2.5 Ethypharm
  • 6.2.6 Macromed
  • 6.2.7 Nektar
  • 6.2.8 QLT
  • 6.2.9 SkyePharma

7 Emerging Drug Delivery Technologies: Transmucosal Drug Delivery

• 7.1 Key Company Involvement in the Field of Transmucosal Drug Delivery
  • 7.1.1 Generex
  • 7.1.2 Nastech
  • 7.1.3 Pherin

8 Emerging Drug Delivery Technologies: Transdermal Drug Delivery

• 8.1 Key Product Profiles
• 8.2 Key Company Involvement in the Field of Transdermal Drug Delivery
  • 8.2.1 3M
  • 8.2.2 Altea Therapeutics
  • 8.2.3 ALZA
  • 8.2.4 Noven

9 Emerging Drug Delivery Technologies: Niche Drug Delivery Technologies

• 9.1 Key Product Profiles
• 9.2 Key Company Involvement in Niche Drug Delivery Technologies
  • 9.2.1 ALZA
  • 9.2.2 Connetics
  • 9.2.3 Inovio
  • 9.2.4 MacroChem
  • 9.2.5 NexMed
  • 9.2.6 pSivida
  • 9.2.7 QLT
  • 9.2.8 SkyePharma

10 Key Drug Delivery Company Profiles

• 10.1 3M
• 10.2 Alkermes
• 10.3 Altea Therapeutics
• 10.4 ALZA (Johnson & Johnson)
• 10.5 Aradigm
• 10.6 Bioject
• 10.7 Biovail
• 10.8 Cardinal Health
• 10.9 Cima Labs (Cephalon)
• 10.10 Connetics
• 10.11 CyDex
• 10.12 Delsite Biotechnologies (Carrington Laboratories)
• 10.13 Depomed
• 10.14 DOR BioPharma
• 10.15 DURECT
• 10.16 Emisphere
• 10.17 Enzon
• 10.18 Ethypharm
• 10.19 Generex
• 10.20 Inovio (formerly Genetronics)
• 10.21 IVAX
• 10.22 MacroChem
• 10.23 MacroMed
• 10.24 Nastech
• 10.25 Nektar
• 10.26 NexMed
• 10.27 Noven
• 10.28 Penwest
• 10.29 Pherin Pharmaceuticals
• 10.30 QLT
• 10.31 SkyePharma
• 10.32 Watson Pharmaceuticals

11 Leading Pharmaceutical Companies Utilizing Drug Delivery Technologies

• 11.1 Pfizer
• 11.2 GlaxoSmithKline
• 11.3 Sanofi-Aventis
• 11.4 Merck
• 11.5 Johnson & Johnson
• 11.6 AstraZeneca
• 11.7 Novartis
• 11.8 Bristol-Myers Squibb
• 11.9 Wyeth
• 11.10 Abbott Labs